Mark Williams - Net Worth and Insider Trading
Mark Williams Net Worth
The estimated net worth of Mark Williams is at least $96 dollars as of 2024-11-13. Mark Williams is the Director of Algernon Pharmaceuticals Inc and owns about 1,200 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $96. Details can be seen in Mark Williams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Williams has not made any transactions after 2022-04-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Williams
Mark Williams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Williams owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .
Click here to see the complete history of Mark Williams’s form 4 insider trades.
Insider Ownership Summary of Mark Williams
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2022-04-11 | Director |
Mark Williams Latest Holdings Summary
Mark Williams currently owns a total of 1 stock. Mark Williams owns 1,200 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of April 11, 2022, with a value of $96.
Latest Holdings of Mark Williams
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2022-04-11 | 1,200 | 0.08 | 96 |
Holding Weightings of Mark Williams
Mark Williams Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Williams has made a total of 3 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the acquisition of 200 shares on April 11, 2022, which cost Mark Williams around $1,220.
Insider Trading History of Mark Williams
- 1
Mark Williams Trading Performance
GuruFocus tracks the stock performance after each of Mark Williams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Williams is -45.76%. GuruFocus also compares Mark Williams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Williams within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Williams's insider trading performs compared to the benchmark.
Performance of Mark Williams
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.39 | | | | | |
| Relative Return to S&P 500(%) | -4.28 | | | | | |
Mark Williams Ownership Network
Ownership Network List of Mark Williams
Ownership Network Relation of Mark Williams
Mark Williams Owned Company Details
What does Algernon Pharmaceuticals Inc do?
Who are the key executives at Algernon Pharmaceuticals Inc?
Mark Williams is the Director of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Director & Senior Officer Christopher Moreau , Senior Officer Christopher Scott Bryan , and Senior Officer James Kinley .
Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary
Over the past 18 months, Mark Williams made no insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN). Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 62,500 shares made by Christopher Moreau , a net purchase of 60,500 shares made by Christopher Scott Bryan , and a net purchase of 12,500 shares made by James Kinley .
In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 135,500 shares were bought by its insiders, resulting in a net purchase of 135,500 shares.
Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Algernon Pharmaceuticals Inc Insider Transactions
Mark Williams Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Williams. Currently GuruFocus does not have mailing address information for Mark Williams.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
